Hints and tips:
Related Special Reports
...Late last year, AstraZeneca agreed to buy its first vaccine company, Icosovax, in a deal worth up to $1.1bn....
...Miels said that the pharmaceutical company has since “rebuilt” its business in China....
...AstraZeneca chief executive Pascal Soriot said on Thursday that the move showed the need for pharmaceutical companies to have “independent” supply chains....
...Swiss company Roche acquired obesity drug developer Carmot Therapeutics for $3.1bn last month, while AstraZeneca signed a $2bn licensing agreement with Eccogene, a Chinese maker of an oral obesity drug in...
...AstraZeneca has agreed to buy oncology biotech Fusion Pharmaceuticals for $2.4bn, as it builds its capacity in a developing field of cancer care....
...The chancellor said that AstraZeneca would invest £650mn in the UK to expand its manufacturing, after the government had encouraged the pharmaceutical company to increase its UK investment....
...AstraZeneca’s jab developed with Oxford university was widely used across the world, but sales fell more than 99 per cent to just $12mn in 2023....
...Dato-DXd, which has been developed with Japanese pharmaceutical company Daiichi Sankyo, and Enhertu, another AstraZeneca treatment, are considered by analysts to be potentially high-earning drugs....
...The tribunal ruled that the largest company in the FTSE 100 discriminated against James Muir — a leading scientist who had been developing the pharmaceutical company’s drug, Truqap — on the basis of a disability...
...He insisted the market was “completely open” for investment from multinationals such as AstraZeneca, adding that the pharmaceutical industry did not suffer from the same kind of “tensions” with China faced...
...The deal is expected to close in the first quarter of next year, AstraZeneca said....
...The National Institute for Health and Care Excellence announced on Tuesday that it would not approve the medication Enhertu, developed by pharmaceutical companies Daiichi Sankyo and AstraZeneca, to treat...
...That ambition, the Association of the British Pharmaceutical Industry says, is contingent on “[making] sure we do not forget the lessons we learned during the pandemic”....
...AstraZeneca updated the label to warn recipients of the concern on April 7 and April 15....
...The partnership adds to a flurry of agreements between big pharmaceutical companies and young AI businesses to build novel disease treatments and cut the costs of developing them....
...The Anglo-Swedish drugmaker has partnered with Daiichi Sankyo, the Japanese pharmaceutical company, on the development of two key “antibody drug conjugates”, which use antibodies to deliver a chemotherapy...
...AstraZeneca shares are down about 4.5 per cent in the year so far....
...Shares in AstraZeneca climbed 3 per cent on Thursday, having lost 9.2 per cent in the year to date period....
...The US market is the engine of the global pharmaceutical industry. Its exceptionally high drug prices help deliver as much as three-quarters of the sector’s global profits....
...London’s FTSE 100 slipped 0.1 per cent, even as shares in UK-based pharmaceuticals group AstraZeneca rose 3.7 per cent after its cancer drug Tagrisso was approved as part of a treatment plan in the US....
...AstraZeneca chair sees past vaccine headwinds Michel Demaré, non-executive chair of the AstraZeneca board, appears bullish about the company’s prospects....
...The deal comes as pharmaceutical companies are gathered in San Francisco for an annual industry conference this week, with GSK rivals Johnson & Johnson striking a $2bn deal to acquire an oncology biotech...
...Companies including UK’s AstraZeneca and Swiss group Roche have recently acquired or licensed weight-loss drugs in an effort to enter a market that analysts expected would exceed $100bn by 2030....
Plus, pharma dealmakers make a comeback in San Francisco confab and private equity ‘whitelists’ challenged
...AstraZeneca has become the latest large pharmaceutical company to sue the US over a law that allows the government to negotiate some drug prices for the first time....
International Edition